Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(5 sites)

China

Fudan University Shanghai Zhongshan Hospital, Shanghai, Shanghai Municipality

Sun Yat-sen University Cancer Center, Guangzhou

Zhejiang Cancer Hospital, Hangzhou

Fudan University, Shanghai

Shanghai Jiao Tong University, Shanghai